Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | SVP, Global Govt Affairs | May 03, 2012 | May 07, 2012 |
| Arcus Biosciences, Inc.RCUS · Entity 4104 | Director | June 06, 2019 | June 10, 2019 |
| INFINITY PHARMACEUTICALS, INC.INFI · Entity 109802 | Director | June 16, 2022 | June 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 03, 2012 · Filed May 07, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,210 |
Reported balance
After 2012-05-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2012-05-03 · Exercise / conversion · Acquired 1,598 · Balance 37,210 |
| Common StockSEC Table I · non-derivative | Direct | 60,612 |
Reported balance
After 2012-05-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2012-05-03 · Exercise / conversion · Acquired 23,402 · Balance 60,612 |
| Common StockSEC Table I · non-derivative | Direct | 70,612 |
Reported balance
After 2012-05-03 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2012-05-03 · Exercise / conversion · Acquired 10,000 · Balance 70,612 |
| Common StockSEC Table I · non-derivative | Direct | 80,612 |
Reported balance
After 2012-05-03 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2012-05-03 · Exercise / conversion · Acquired 10,000 · Balance 80,612 |
| Common StockSEC Table I · non-derivative | Direct | 90,612 |
Reported balance
After 2012-05-03 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2012-05-03 · Exercise / conversion · Acquired 10,000 · Balance 90,612 |
| Common StockSEC Table I · non-derivative | Direct | 35,612 |
Reported balance
After 2012-05-03 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2012-05-03 · Sale · Disposed 55,000 · Balance 35,612 F1: The price reported is an average price. The prices ranged from $70.545 to $70.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| Iso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-05-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2012-05-03 · Exercise / conversion · Disposed 1,598 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-05-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2012-05-03 · Exercise / conversion · Disposed 23,402 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.13 · Expires 2015-04-29 | Direct | 0 |
Reported balance
After 2012-05-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2012-05-03 · Exercise / conversion · Disposed 10,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.44 · Expires 2016-04-28 | Direct | 10,000 |
Reported balance
After 2012-05-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-05-03 · Exercise / conversion · Disposed 10,000 · Balance 10,000 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.43 · Expires 2020-04-26 | Direct | 20,000 |
Reported balance
After 2012-05-03 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-05-03 · Exercise / conversion · Disposed 10,000 · Balance 20,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is an average price. The prices ranged from $70.545 to $70.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
Arcus Biosciences, Inc.
Report date June 06, 2019 · Filed June 10, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.99 · Expires 2029-06-05 | Direct | 35,000 |
Reported balance
After 2019-06-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-06 · Grant · Acquired 35,000 · Balance 35,000 F1: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.
INFINITY PHARMACEUTICALS, INC.
Report date June 16, 2022 · Filed June 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.68 · Expires 2032-06-16 | Direct | 45,000 |
Reported balance
After 2022-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-16 · Grant · Acquired 45,000 · Balance 45,000 F1: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2022 Filed Jun 16, 2022 20:52 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001140361-22-023321 · form4.xml · derivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:17 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001140361-21-020650 · form4.xml · derivative · entry 2 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:17 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantCommon Stock | 3,061 | $3.43 | $10,499.23 |
DisclosureSEC source: 0001140361-21-020650 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,775 F1 · shares: Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of approximately 25% of such person's $42,000 annual retainer for service as a director. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 08:30 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.92 | $0.00 |
DisclosureSEC source: 0000899243-20-017001 · doc4.xml · derivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 16:06 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0000899243-19-017004 · doc4.xml · derivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-06-12 F1 · derivative.exercise_date: The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 18:59 UTC | Arcus Biosciences, Inc. RCUS · Entity 4104 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001209191-19-035740 · doc4.xml · derivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2029-06-05 F1 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 08:30 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantCommon Stock | 5,714 | $1.75 | $9,999.50 |
DisclosureSEC source: 0000899243-18-016527 · doc4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · shares: Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of approximately 25% of such person's $40,000 annual retainer for service as a director. Read SEC document |
| April 01, 2018 Filed Apr 2, 2018 20:22 UTC | INFINITY PHARMACEUTICALS, INC. INFI · Entity 109802 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0000899243-18-009133 · doc4.xml · derivative · entry 1 BEIER DAVID W · CIK 0001187054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-04-01 F1 · derivative.exercise_price: Represents the closing sale price per share of the Issuer's common stock as reported on the Nasdaq Global Select Market on the trading day immediately prior to the date of grant. F2 · derivative.exercise_date: The option vests as to 1/8th of the shares on June 30, 2018 and as to 1/8th of the shares at the end of each calendar quarter thereafter, provided that the holder continues to serve as a director of the Issuer. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · derivative · entry 11 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · derivative · entry 10 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · derivative · entry 9 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 23,402 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · derivative · entry 8 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,402 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionIso (Right to Buy) · Derivative | 1,598 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · derivative · entry 7 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,598 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 55,000 | $70.72 | $3,889,369.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · nonDerivative · entry 6 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,612 F1 · price: The price reported is an average price. The prices ranged from $70.545 to $70.77 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $58.43 | $584,300.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · nonDerivative · entry 5 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $50.44 | $504,400.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · nonDerivative · entry 4 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $42.13 | $421,300.00 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · nonDerivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 23,402 | $62.55 | $1,463,795.10 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 7, 2012 21:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,598 | $62.55 | $99,954.90 |
DisclosureSEC source: 0001127602-12-016070 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2012 Filed May 2, 2012 00:37 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,267 | $71.64 | $90,767.88 |
DisclosureSEC source: 0001127602-12-015243 · form4.xml · nonDerivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,612 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2012 Filed May 2, 2012 00:37 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 634 | $71.64 | $45,419.76 |
DisclosureSEC source: 0001127602-12-015243 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,879 Read SEC document |
| April 27, 2012 Filed May 2, 2012 00:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015243 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,513 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 21:02 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 645 | $70.19 | $45,272.55 |
DisclosureSEC source: 0001127602-12-014943 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,163 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,326 | $68.26 | $158,772.76 |
DisclosureSEC source: 0001127602-12-011439 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,808 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 14, 2012 Filed Mar 15, 2012 23:35 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-010806 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,134 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| February 07, 2012 Filed Feb 8, 2012 01:32 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-004524 · form4.xml · derivative · entry 5 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2012 Filed Feb 8, 2012 01:32 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-004524 · form4.xml · derivative · entry 4 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2012 Filed Feb 8, 2012 01:32 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $68.88 | $1,377,678.00 |
DisclosureSEC source: 0001127602-12-004524 · form4.xml · nonDerivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 F1 · price: The price reported is an average price. The prices ranged from $68.84 to $68.91 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| February 07, 2012 Filed Feb 8, 2012 01:32 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $58.43 | $584,300.00 |
DisclosureSEC source: 0001127602-12-004524 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2012 Filed Feb 8, 2012 01:32 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $50.44 | $504,400.00 |
DisclosureSEC source: 0001127602-12-004524 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · derivative · entry 7 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · derivative · entry 6 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 30,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · derivative · entry 5 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2012-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 57,500 | $68.47 | $3,936,904.25 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · nonDerivative · entry 4 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 F1 · price: The price reported is an average price. The prices ranged from $68.38 to $68.495 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 10,000 | $50.44 | $504,400.00 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · nonDerivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $42.13 | $1,263,900.00 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 01:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 17,500 | $58.61 | $1,025,675.00 |
DisclosureSEC source: 0001127602-12-003243 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP, Global Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2011 Filed Aug 15, 2011 22:50 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,000 | $51.56 | $773,470.50 |
DisclosureSEC source: 0001127602-11-023655 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 F1 · price: The price reported is an average price. The prices ranged from $51.68 to $50.18 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,248 | $57.14 | $71,310.72 |
DisclosureSEC source: 0001127602-11-014432 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,902 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2011 Filed May 2, 2011 23:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 561 | $56.82 | $31,876.02 |
DisclosureSEC source: 0001127602-11-014432 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,150 Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 490 | $54.69 | $26,798.10 |
DisclosureSEC source: 0001127602-11-013878 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,711 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:03 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 26,250 | $54.69 Strike: $54.69 | $1,435,612.50 |
DisclosureSEC source: 0001127602-11-013878 · form4.xml · derivative · entry 3 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2021-04-25 F3 · derivative.exercise_date: These non-qualified stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:03 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013878 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,201 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 11, 2011 Filed Mar 15, 2011 22:36 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,835 | $51.84 | $146,966.40 |
DisclosureSEC source: 0001127602-11-010290 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,701 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:28 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 8,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-009089 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,536 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| August 13, 2010 Filed Aug 16, 2010 21:53 UTC | AMGEN INC AMGN · Entity 2832 | Disposition to issuerCommon Stock | 13,000 | $54.94 | $714,220.00 |
DisclosureSEC source: 0001127602-10-021414 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,141 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| July 31, 2010 Filed Aug 3, 2010 22:27 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 11,081 | $54.53 | $604,246.93 |
DisclosureSEC source: 0001127602-10-020572 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,141 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:49 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 974 | $58.18 | $56,667.32 |
DisclosureSEC source: 0001127602-10-012669 · form4.xml · nonDerivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,222 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 25,000 RSUs which fully vest on 7/31/2010; 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal installments of 1,450 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:49 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 491 | $57.84 | $28,399.44 |
DisclosureSEC source: 0001127602-10-012669 · form4.xml · nonDerivative · entry 1 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,196 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 40,000 | $58.43 Strike: $58.43 | $2,337,200.00 |
DisclosureSEC source: 0001127602-10-012268 · form4.xml · derivative · entry 2 BEIER DAVID W · CIK 0001187054 · SVP Global Govt & Corp Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2020-04-26 F3 · derivative.exercise_date: These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.